In this episode of "The Top Line," we talk with Dr. Reanne Moore, an associate professor of psychiatry at the University of California San Diego, about the state of digital phenotyping. We also cover the vaccine patent lawsuits, the smallest insulin pump, and the rest of the week's headlines.
To learn more about the topics in this episode:
- Nominations for Fierce Biotech's 2023 Fierce 15 close Friday—three more days to submit
- The Future of Biotech
- ADC puts Zynlonta study on hold after 7 patient deaths, 5 other severe adverse events
- Tandem crosses FDA finish line with nod for miniaturized insulin pump
- Moderna mounts 2 new patent lawsuits against mRNA rivals Pfizer, BioNTech: report
- Novartis retreats from TIGIT, handing $300M candidate back to BeiGene
- Illumina receives record €432M fine from EU for false start on Grail deal